• Thu, February 29, 2024
John McNulty Downgraded (CC) to Sell and Decreased Target to $19 on, Feb 29th, 2024
John McNulty of BMO Capital, Downgraded "The Chemours Company" (CC) to Sell and Decreased Target from $45 to $19 on, Feb 29th, 2024.
John has made no other calls on CC in the last 4 months.
There are 5 other peers that have a rating on CC. Out of the 5 peers that are also analyzing CC, 4 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Zekauskas of "JP Morgan" Maintained at Hold with Decreased Target to $26 on, Tuesday, November 7th, 2023
- Duffy Fischer of "Goldman Sachs" Maintained at Hold with Decreased Target to $30 on, Tuesday, October 31st, 2023
- Michael Leithead of "Barclays" Maintained at Hold with Decreased Target to $28 on, Monday, October 30th, 2023
- Vincent Andrews of "Morgan Stanley" Maintained at Hold with Decreased Target to $28 on, Monday, October 30th, 2023
This is the rating of the analyst that currently disagrees with John
- Arun Viswanathan of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $40 on, Friday, December 1st, 2023
Like: 👍
